CorMedix (CRMD) Other Accumulated Expenses (2015 - 2025)

CorMedix has reported Other Accumulated Expenses for 11 years, with the latest figure at $2.3 million in Q4 2025.

• Quarterly Other Accumulated Expenses rose 1749.19% year-over-year to $2.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (up 1749.19% YoY) and the FY2025 annual result came in at $2.3 million, up 1749.19% from the prior year.
• Other Accumulated Expenses climbed to $2.3 million in Q4 2025 per CRMD's latest filing, from $278684.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $2.3 million in Q4 2025 and troughed at $54763.0 in Q3 2023.
• A 5-year average of $242973.4 and a median of $112783.0 in 2021 frame the typical range for Other Accumulated Expenses.
• The widest YoY moves for Other Accumulated Expenses: up 1749.19% in 2025, down 68.76% in 2025.
• Over 5 years, Other Accumulated Expenses stood at $94736.0 in 2021, then sank by 31.96% to $64456.0 in 2022, then jumped by 127.01% to $146324.0 in 2023, then slipped by 15.26% to $124000.0 in 2024, then surged by 1749.19% to $2.3 million in 2025.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $2.3 million, $278684.0, and $136298.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.